论文部分内容阅读
目的:了解骨肉瘤病例中施予保肢手术疗法+吡柔比星辅助化疗疗法+术后康复训练的意义。方法:选择65例患上骨肉瘤且于2011年03月至2014年09月进入本院的确诊者,以专业治疗工作流程的差异分组,其中甲组34例施予保肢手术疗法+吡柔比星辅助化疗疗法+术后康复疗法,乙组31例施予保肢疗法,评定入选病例肢体功能,同时随访、记录其病变组织转移/复发率及其生存率。结果:甲组34例肢体功能临床优良率70.59%,乙组31例是54.84%,(P<0.05);甲组3例病变组织转移/复发,乙组12例,(P<0.05);甲组术后三年有27例存活,乙组16例,(P<0.05)。结论:肿瘤科给予骨肉瘤病例治疗时,施予保肢手术疗法+吡柔比星辅助化疗疗法+术后康复训练更为可靠,推荐视作优选措施。
Objective: To understand the significance of limb salvage surgery plus pirarubicin adjuvant chemotherapy plus postoperative rehabilitation training in patients with osteosarcoma. Methods: Totally 65 patients with osteosarcoma who were admitted to our hospital from March 2011 to September 2014 were selected and divided into groups according to the professional treatment workflow. 34 patients in group A received limb salvage surgery plus pirarubicin Adjuvant chemotherapy + postoperative rehabilitation therapy, 31 cases of group B given limb salvage therapy, assessment of selected cases of limb function, at the same time follow-up, record the pathological tissue metastasis / recurrence rate and survival rate. Results: The excellent and good rate of limb function in group A was 70.59%, 31 cases in group B were 54.84% (P <0.05), and 3 cases in group A were metastasis / recurrence of group B (P <0.05). There were 27 cases survived three years after operation, 16 cases in group B (P <0.05). Conclusions: Prophylactic limb salvage surgery + pirarubicin adjuvant chemotherapy + postoperative rehabilitation training is more reliable when oncology is given to patients with osteosarcoma. The recommendation is regarded as a preferable measure.